Novartis has reported that its experimental drug ianalumab met the primary goal in a phase 3 trial for […]
Category: News
Eli Lilly and Company has announced that Anne White, executive vice president and president of Lilly Neuroscience, will […]
ANGLE has announced a collaboration with Myriad Genetics to assess whether circulating tumour cell (CTC) DNA harvested from […]
Friends of Cancer Research has announced a new collaboration with global clinical research organisation, MMS, to develop decision […]
Upperton Pharma Solutions has been awarded funding under the first VaxHub Sustainable Platform Funding Call to support the […]
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to izalontamab brengitecan (iza-bren), an […]
Merck’s therapy becomes first authorised option for aggressive soft tissue tumours
Project aims to improve global immunisation through needle-free delivery
Company shifts focus to phase 3 VE303 trial in recurrent C. difficile infection
Lilly’s study finds tirzepatide delivers broader health improvements